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ABSTRACT
Purpose
Opioid therapy is commonly prescribed to combat surgical pain in hospitals across the United
States and is associated with many negative side effects including dependence and nausea. The purpose
of this study was to retrospectively examine the effects of scheduling acetaminophen and
methocarbamol administration postoperatively throughout the cardiac surgery patients’ hospital stay.
Through retrospective chart reviews, the aims of postoperative opioid use, postoperative opioid use
according to hospital length of stay, antiemetic use, and opioid prescription at discharge were compared
between two cohorts: a scheduled acetaminophen and methocarbamol cohort and a non-scheduled
cohort.
Setting & Population
The study takes place at The University of Kentucky’s Cardiovascular Intensive Care Unit and
telemetry floors at Albert B. Chandler Medical Center in Lexington, Kentucky. Coronary artery bypass
graft (CABG) and valve replacement surgical patients were the target population. A total of 77 patients
were included in this retrospective study divided into two cohorts. The scheduled cohort had 27 patients
and the non-scheduled cohort had 50. The mean age for scheduled cohort was 60.8 while nonscheduled
was 59.5 while 97.4 percent of the participants were white.
Results
The scheduled cohort had a sum of opioids mean of 23.5 and the non-scheduled cohort had a
sum of opioids mean of 25.5. There was no significant difference in means between the two cohorts (p=
.47). There was no significant difference between the two cohorts of hospital length of stay less than
one week and greater than one week (p=.07, .533 respectively); however, less than one week, the p
value was lower (p=.07) and when examining the mean scores of scheduled less than one week with a
mean of 15.6, and non- scheduled less than one week with a mean of 22.1; clinical relevance can be
argued. No significant association existed (p= .753) between those discharged home on opioids between
the two cohorts; however, clinical relevance is argued. No significant difference between the two
cohorts and antiemetic use (p= .107).
Conclusion
Limitations to the study included the setting being a single center study with a minimally diverse
patient population and strict inclusion/ exclusion criteria that impeded sample size. When developing
future studies, consideration should be given to hospital LOS due to this study’s clinically relevant
findings. Future research is needed for cardiac surgery patients and ways to mitigate those discharged
home on opioids. Future studies could alter the “scheduling” definition to include patients receiving

acetaminophen and methocarbamol greater than or equal to four times in a 24-hour period (+ or – four
hours). Future research could also include more in-depth communication among all disciplines involved
including ways to mitigate the technological errors encountered in this study. Dissemination of the
surgical guidelines published by the American Pain Society (2016) and The Enhanced Recovery After
Surgery Society (2019) that promote scheduling acetaminophen postoperatively could occur in an
educational in-person session to the cardiac surgery service line and serve as beneficial along with this
study’s clinically relevant findings. Notable ethical concerns include the primary investigator’s
employment as a nurse within UK’s Cardiovascular Intensive Care Unit. This study contributes to the
knowledge of the effects related to scheduling postoperative acetaminophen and methocarbamol
among cardiac surgery patients and has the potential to offer insight on future study designs.
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BACKGROUND and SIGNIFICANCE
Opioid therapy is commonly prescribed to combat surgical pain in hospitals across the United
States and is associated with many negative side effects including dependence, constipation, and nausea
(Chisolm-Burns, et al., 2016). High rates of post-surgical opioid addiction span the United States;
(Compton, Mena Sethi, & Sigman, 2017) meanwhile, Kentucky is the fifth leading state in the nation’s
opioid epidemic with a 40 percent increase in drug overdose rates in the last five years (Office of Drug
Control Policy, 2018). One in eight cardiac surgery patients are at risk for opioid dependence and
patients who begin taking opioids for the first time, known medically as opioid naïve, after a heart
operation are at risk for chronic use (The Society of Thoracic Surgeons, 2019). Opioid dependence is not
the only side effect warranting attention. Nausea has been reported to occur in 25 percent of patients
treated with opioids (Kane-Gill et al., 2014; American Pain Society, 2016).
Incision-related and intraoperative bone and tissue manipulation are just some of the many
common causes of postoperative pain experienced by surgical patients (Mueller et at., 2000). Cardiac
surgery patients may experience previously stated causes of surgical pain, in addition to chest tube
associated pain (Mueller et al., 2000). Chest tubes are placed in cardiac surgery patients to drain
intrathoracic fluids caused from surgery and to facilitate lung expansion; however, manipulation and
movement of these chest tubes during the postoperative recovery process can produce significant pain
for the patient (Mueller et al., 2000). Chest, upper-back and shoulder muscle tightness are common
sources of cardiac surgery post-operative pain as well (The Society of Thoracic Surgeons, 2009).
Opioid therapy is the first line treatment therapy for pain among cardiac surgery patients in the
cardiovascular intensive care unit at the University of Kentucky Chandler Medical Center. Adjunctive
pain management therapy is often recognized as an alternative way to reduce opioid use
postoperatively. Scheduling acetaminophen and methocarbamol is intermittently used in my unit among
cardiac surgery patients but is not standard therapy. Two surgical guidelines suggest clinicians provide
adults with acetaminophen in conjunction with opioids (American Pain Society’s Clinical Practice
Guideline on Management of Postoperative Pain, 2016; Enhanced Recovery After Surgery Society’s
Guidelines for Care in Perioperative Cardiac Surgery, 2019). The combination of opioids and
acetaminophen is associated with less postoperative pain and/or opioid use compared to opioids alone
(American Pain Society, 2016). Both surgical guidelines previously mentioned also recommend
scheduling acetaminophen with postoperative CABG patients (American Pain Society, 2016; Engelman et
al. 2019). Along with acetaminophen use, adjunctive methocarbamol, a skeletal muscle relaxant, is
associated with diminished postoperative pain and opioid consumption (Hidalgo & Pusic, 2005; Looke &
Kluth, 2013).
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PURPOSE STATEMENT
The purpose of this study was to examine effects of scheduled acetaminophen and
methocarbamol administration on postoperative cardiac surgery patients during their entire hospital
stay. This was completed through retrospective chart review comparisons between a historical control,
referred to as non-scheduled cohort, and the scheduled acetaminophen/ methocarbamol intervention
cohort (referred to as the scheduled cohort).The following aims and associated objectives guided this
research:
Aim One: Does scheduling acetaminophen and methocarbamol postoperatively impact the average
postoperative opioid use among cohorts?
•

Objective One- Postoperative opioid use per patient as evidenced by total number of
occurrences of opioid administrations (oxycodone, hydrocodone, morphine and
hydromorphone) on patients' medication administration records (MARs) throughout entire
hospital length of stay.

Aim Two: Does scheduling acetaminophen and methocarbamol postoperatively impact the average
postoperative opioid use among cohorts when examining patients with hospital length of stay less
than one week and greater than one week?
•

Objective Two- Postoperative opioid use per patient as evidenced by total number of
occurrences of opioid administrations on patients’ MARs for patients with hospital length of
stay (LOS) less than one week and more than one week throughout hospital stay. Aim
Three: Does scheduling acetaminophen and methocarbamol postoperatively impact the
average amount of those discharged home on opioids among cohorts?

•

Objective Three- Side effect of potential dependence as evidenced by number of opioid
prescriptions at discharge.

Aim Four: Does scheduling acetaminophen and methocarbamol postoperatively impact the average
postoperative antiemetic use among cohorts?
•

Objective Four- Side effect of postoperative nausea as evidenced by total number of
occurrences of ondansetron and promethazine administrations on MARs throughout
hospital stay.
THEORETICAL and CONCEPTUAL FRAMEWORK

My DNP project was grounded in Kolcaba’s Comfort Theory (2002) which is patient-centered and
central to nursing values. Kolcaba identifies three types of comfort:
1. Relief (a state in which comfort needs are met)
2. Ease (the state of calm or contentment)
8

3. Transcendence (the state in which one overcomes and rises above problems or pain)
(Kolcaba, 2002).
Kolcaba’s Comfort Theory states when patients are most comfortable, they engage more in
health-seeking behaviors that include internal and external behaviors. In turn, when patients engage in
health-seeking behaviors more, the institution benefits in such areas as reduced cost of care, length of
stay, increased patient satisfaction, enhanced financial stability, and more positive publicity (Kolcaba,
2002). Kolcaba’s Comfort Theory can be applied to this DNP final project through the conceptual
framework illustrated in appendix one. This conceptual framework among cardiac surgical patients
supports an individualized patient approach and highlights the optimal types of comfort they experience
while recovering postoperatively via the scheduling of acetaminophen and methocarbamol. First,
patients experience a state of pain relief after scheduled acetaminophen and methocarbamol is
administered. Next, patients experience the ease, or calm, of the new postoperative pain management
therapy working to minimize pain and possibly reduce postoperative opioid use and associated side
effects as they progress through their hospital stay. Finally, transcendence of the patient occurs after
discharge when they leave the hospital and overcome the risk of experiencing postoperative opioid
associated side effects.

LITERATURE REVIEW
A literature review was done to synthesize the existing published, peer-reviewed research
involving postoperative opioid-associated side effects of dependence and nausea to provide support for
scheduling acetaminophen and/or methocarbamol postoperatively. The following searches produced 17
studies related to opioid use, acetaminophen, and methocarbamol use in the surgical population:
postoperative cardiac surgery/ surgical patients, postoperative opioid use, acetaminophen and
methocarbamol postoperative opioid use, postoperative opioid complications.
Opioid therapy is commonly prescribed to combat surgical pain in hospitals. High rates of
postsurgical opioid addiction span the United States; (Compton et al., 2017) meanwhile, Kentucky is the
fifth leading state in the nation’s opioid epidemic with a 40 percent increase in overdose rates in the last
five years (Office of Drug Control Policy, 2018). Opioid exposure before surgery is a known risk factor for
abuse postoperatively (Compton et al., 2017; Hah, Bateman, Ratliff, Curtin, & Sun, 2017) but what about
those with no history of opioid exposure? Multiple retrospective cohort studies have shown
postoperative opioid use among opioid naïve surgical patients to be associated with opioid dependence
(Brescia et al., 2019; Sun, Darnell, Baker, & Mackey, 2016; Brummett et al., 2017; Clarke et al., 2014;
Calcaterra et al., 2015; Mechcatie, 2018) suggesting all those exposed to opioids postoperatively are at
risk for dependence including those opioid naïve and tolerant.
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When reviewing opioid naïve postoperative patients, Brescia et al. (2019)’s study highlighted
one in eight cardiac (12.5 percent) opioid naïve surgery patients are at risk for opioid dependence while
Sun et al., (2016) concluded a variety of surgical procedures are affiliated with opioid dependence
among opioid naïve patients including total knee arthroplasty, open and laparoscopic cholecystectomy,
open appendectomy, cesarean delivery, functional endoscopic sinus surgery, cataract surgery, and
transurethral prostate resection. Brummett et al. (2017) discovered among opioid naïve major and
minor surgical patients that 5.9- 6.5 percent developed new, persistent opioid use 90-180 days after the
surgical procedure. One Canadian retrospective cohort study found among opioid naïve patients who
had major elective surgery including cardiac procedures- 49 percent were discharged home with an
opioid prescription while 3.1 percent continued to receive opioids for more than 90 days postoperatively
(Clarke, Soneji, Ko, Yun, & Wijeysundera, 2014). Narrative reviews infer opioids administered during and
after surgery may precipitate opioid dependence despite opioid naïve or tolerant status (Hah, Bateman,
Ratliff, Curtin, & Sun, 2017; Clark & Schumacher, 2017).
One retrospective cohort study at a single institution examined opioid dependence among
CABG patients (Hirjii, et al., 2019). The study defined postoperative opioid dependence as having an
opioid prescription 90 days after discharge including those participants that were preoperatively opioid
naïve and opioid exposed (Hirjii, et al., 2019). The study concluded 3.2 percent of opioid naïve and 21.7
percent of opioid exposed patients were opioid dependent 90 days after discharge while 72 percent of
opioid naïve postoperative CABG patients were discharged home with opioids (Hirjii, et al., 2019)
Multiple studies associated postoperative opioid dependence with opioid prescription at
discharge (Hirijii et al., 2019; Clarke et al., 2014; Brummett et al., 2017). In fact, two retrospective
cohorts concluded long duration of postoperative opioid prescriptions as a greater indicator of abuse/
dependence than increased dosage rates (Mechcatie, 2018; Shah, Hayes & Martin, 2017).
According to the literature, postoperative opioid side effects do not just involve dependence.
Many sources cite constipation, respiratory depression, and nausea as some of the most commonly
experienced opioid-related side effects (Kane-Gill et al., 2014; Swegle & Logemann, 2006). Nausea has
been reported to occur in 25 percent of patients treated with opioids while constipation is the most
common adverse effect (Kane-Gill et al., 2014; American Pain Society, 2016).
The opioid associated adverse drug events named above (OAADE), also known as opioid-related
side effects, do not come without consequence. The presence of OAADEs was associated with a 29
percent increase in hospitalization costs, and a 55 percent longer length of stay (Urman et al., 2019).
OAADEs increased hospital length of stay by as much as 4 days in one systematic review (Kane-Gill et al.,
2014). Few prospective studies exist relating cost and consequence of opioid associated adverse drug
events among postoperative patients in general, as well as postoperative cardiac patients.
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Postoperative opioid dependence and the associated side effect of nausea are surgical
complications deserving attention and a directed effort at mitigating exposure among opioid naïve and
tolerant patients postoperatively. Postoperative opioids should be kept to a minimum or avoided
entirely (Enhanced Recovery After Surgery Society and European Society of Thoracic Surgeons, 2019).
More prospective random control trials and cohort studies are needed examining the cardiac surgery
patient population and associated their specific opioid-related side effects.
Adjunctive pain management therapy is often recognized as an alternative way to reduce opioid
use postoperatively. Two surgical guidelines suggest clinicians provide adults with acetaminophen in
conjunction with opioids (American Pain Society’s Clinical Practice Guideline on Management of
Postoperative Pain, 2016; Enhanced Recovery After Surgery Society’s Guidelines for Care in
Perioperative Cardiac Surgery, 2019). The combination of opioids and acetaminophen is associated with
less postoperative pain and/or opioid use compared to opioids alone (American Pain Society, 2016;
Engelman et al., 2019). Both surgical guidelines previously mentioned also recommend scheduling
acetaminophen with postoperative CABG patients (American Pain Society, 2016; Engelman et al., 2019).
Acetaminophen is a vital part of postoperative pain control and reduces opioid consumption by as much
as 20 percent according to another set of postoperative pain management guidelines published by
Enhanced Recovery After Surgery Society and European Society of Thoracic Surgeons (2019).
Utilization of acetaminophen (intravenous and oral) was associated with decreased opioid use
postoperatively among studies (Looke & Kluth, 2013; MicNicol et al., 2011; Jelacic et al., 2016). Single
dose acetaminophen was studied for postoperative pain in adults (MicNicol et al., 2016). A systematic
review (Toms, McQuay, Derry, & Moore, 2008) provided support for acetaminophen serving as effective
analgesia among 37- 50 percent of patients experiencing acute postoperative pain. Clearly, more studies
are warranted examining scheduled acetaminophen efficacy among the cardiac surgery patient
population where more than a single dose of acetaminophen will be administered. Comparative analysis
of postoperative opioid consumption alongside scheduled oral acetaminophen administration should be
examined to determine acetaminophen’s association with postoperative opioid use and effects.
One randomized, placebo-controlled trial claimed a 27 percent decrease in 24-hour
postoperative opioid use among cardiac surgery patients after scheduled IV acetaminophen for the first
24 hours (Jelacic et al., 2016). Limitations included a small sample size of 68 participants confined to one
hospital setting. Conversely, another single-center randomized control trial repeated IV acetaminophen
administration postoperatively for 24 hours among cardiac surgery patients with a slightly bigger sample
size of 147 patients to yield no reduction in opioid use among the participants (Mamoun et al., 2016).
These studies contribute to an increased need for more research involving scheduled postoperative
acetaminophen IV and PO administration among the cardiac surgery patient population.
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Methocarbamol is a skeletal muscle relaxant originally developed for musculoskeletal pain
(Hidalgo & Pusic, 2005). Studies have associated methocarbamol use with diminished postoperative pain
and opioid consumption (Hidalgo & Pusic, 2005; Looke & Kluth, 2013), however, limited data exists
examining it’s efficacy among postoperative cardiac surgery patients. Looke & Kluth (2013) examined
preoperative acetaminophen IV and methocarbamol PO administration on postoperative opioid use
among total hip and knee replacement surgical patients for 48-hours postoperatively resulting in a
significant difference in postoperative mean opioid use. The study also suggests a role for
methocarbamol when muscle spasm is of concern (Looke & Kluth, 2013). One could argue mediastinal
and intercostal muscle spasms play a role in postoperative cardiac surgery pain while the Society of
Thoracic Surgeons (2009) claim chest, upper-back and shoulder muscle tightness are common sources of
cardiac surgery postoperative pain. Postoperative methocarbamol and acetaminophen were not
examined among the total hip and knee replacement surgical patient population. Studies involving the
cardiac surgery patient and methocarbamol administration are warranted.
To summarize this review of literature, limited research exists among the cardiac surgical patient
population examining postoperative opioid dependence and associated side effect of nausea. Limited
evidence exists examining the efficacy of scheduling acetaminophen and methocarbamol
postoperatively among all surgical patients including the cardiac surgery patient population. Synthesis of
evidence findings support postoperative opioid use among opioid naïve and tolerant patients as a risk
for opioid dependence as well as opioid prescriptions at discharge. Few prospective studies exist relating
cost and consequence of opioid associated side effects among postoperative patients in general, as well
as in postoperative cardiac surgery patients. Acetaminophen is supported by two postoperative pain
management guidelines in cardiac surgery while limited studies exist examining methocarbamol
postoperatively. See appendix two for a full synthesis of evidence table.

DESIGN
This project involved retrospective chart review comparisons between two cohorts. The first
cohort, or scheduled cohort, involved scheduling acetaminophen and methocarbamol administration
postoperatively to cardiac surgery patients and the second cohort involved a non-scheduled control not
receiving the medications on a scheduled basis. The non-scheduled cohort was still offered the
medications (acetaminophen and methocarbamol) on an as needed basis. Scheduled was defined as
receiving acetaminophen and methocarbamol each greater than or equal to four times in 24 hours;
patients receiving both acetaminophen and methocarbamol greater than or equal to four times in a
24hour period during their hospital stay were placed into the scheduled cohort. Individuals receiving the
medications less than four times in a 24 -hour period were assigned to the non-scheduled cohort. Both
12

cohorts were offered standard postoperative opioid therapy. The study involved 77 total patients. The
scheduled cohort consisted of 27 patients and the non-scheduled cohort consisted of 50 patients.
Retrospective chart reviews of CABG and valve surgery patients included those admitted to the hospital
from January 1, 2017- June 1, 2019.
Data was collected initially from the University of Kentucky’s Center for Clinical and Translational
Research (CCTS) and validated through electronic health record (EHR) chart reviews conducted by the
primary investigator and included demographic statistics such as age, gender, procedure type, and
hospital LOS as well as the following objective one through four.

METHODS
Study Setting
The University of Kentucky’s Cardiovascular Intensive Care Unit (CVICU) is where this study’s
patients were admitted and spent the majority of their hospital stay. The patients were then transferred
from the CVICU to the associated step-down telemetry floors. The CVICU is comprised of 32 beds and
more than 30 providers while being known as one of the largest cardiovascular ICU’s in the nation
offering some of the most innovative technological therapies. These therapies include left/ right
ventricular assist devices, extracorporeal membrane oxygenation, continuous renal replacement
therapy, temporary percutaneous ventricular assist devices, intra-aortic balloon pumps, total artificial
hearts, ultrasound enhanced pulmonary artery thrombolysis, coronary artery bypass grafts, valve
replacements, coronary artery stents, heart and lung transplants, esophagectomies, pneumonectomies,
and lobectomies. Nurses in the intensive care unit are staffed to provide care for one or two patients
depending on acuity. Surgical patients are recovered in the CVICU and then transferred to the service
line’s acute care floor to prepare for discharge.
UK Healthcare’s mission is dedicated to the health of the people of Kentucky, striving to provide
advanced patient care and serving as an information resource (University of Kentucky Albert B. Chandler
Medical Center, 2019). UK Healthcare also has a strategic plan containing a foundation related to
patient-centered care. This project aligned with UK Healthcare’s mission and strategic plan because it
examined ways to reduce patients’ postoperative opioid use in order to reduce opioid-related
complications. This project is focused on examining potentially harmful opioid related side effects for
the patient (patient-centered) while also studying the effects of scheduling evidenced-based
medications (acetaminophen and methocarbamol) postoperatively.

Target Population
The target population involved cardiac surgery patients specifically coronary artery bypass
grafts, and valve replacements taking place January 1, 2017- June 1, 2019. Participant inclusion criteria
13

for both cohorts included: males and females, all ages greater than 18 years of age, valve and/or
coronary artery bypass graft surgery, and all presenting ethnicities. Exclusion criteria for both cohorts
was non-valve or non-coronary artery bypass graft cardiothoracic surgical patients, patients less than 18
years of age, patients expiring during their hospital stay, pregnant patients, patients on postoperative
opioid PCAs or continuous opioid infusions, patients with chronic pain disorders (fibromyalgia, chronic
back pain), patients with diagnosed opioid use disorder, patients with a hospital length of stay greater
than 14 days, and patients requiring mechanical circulatory support postoperatively such as
extracorporeal membrane oxygenation or left/ right ventricular assist devices. Patients were also
excluded from the study if they only received one or none of the medications (acetaminophen and
methocarbamol) in the scheduled or non-scheduled cohorts. The two cohorts were divided into two
cohorts; the scheduled cohort patients received acetaminophen (intravenous and/ or by mouth) and
methocarbamol greater than or equal to four times in a 24-hour period during their hospital stay. The
non-scheduled cohort involved patients receiving acetaminophen (intravenous and/ or by mouth) and
methocarbamol less than four times in a 24-hour period during their hospital stay.

Facilitators and Barriers
According to Melnyk and Fineout-Overholt (2015), facilitators are individuals carrying out a
specific role with certain education and skills to ease the transition of applying evidence-based practice.
Facilitators of this DNP project were the CVICU managers, providers, nurses, pharmacists, university
statisticians, office of research representatives, and committee members/ clinical mentors- all of whom
were willing to offer input and guidance to facilitate the success of this study. Barriers of this
retrospective study included the data collection technological errors from medication counts on all
charts. The PI was then faced with a time constraint of recounting all medications involved in the
objectives of this study for every patient to verify an accurate medication count. The PI and CCTS data
collector also encountered a language barrier involving miscommunication between medical and
nonmedical backgrounds. This miscommunication was unintentional and required the PI and data
collector to meet several times to resubmit data collection algorithms for the computerized system to
collect the data.
To complete this study, consistent consultation between multiple disciplines had to occur in
order to enable creative process development strategies. These consultation methods between CCTS,
pharmacy, statistician, and committee members involved emails, and in person meetings occurring
weekly to monthly at various project stages. These strategies created systems that facilitated the data
collection process on trial and error basis.
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Procedure
UK Institutional Review Board (IRB) exempt approval was obtained for this project on August 26,
2019 and the study will remain open until August 25, 2025. Informed consent was waived due to the
minimal risk to the subject (retrospective study), the rights and welfare of subjects were not adversely
affected, and the research could not have practically been achieved without the requested waiver. A
waiver of authorization was also obtained. The University of Kentucky Chief of Cardiac Surgery Division,
Dr. Michael Sekela formally approved this study.
Participants’ EHR data was initially collected and deidentified via CCTS and medical record
numbers were given to the primary investigator (PI) in order to verify the data’s accuracy. The PI verified
accuracy of all participating patients’ data after receiving it from CCTS. The data was collected, verified,
and stored on an encrypted, password protected personal laptop.
The chart-based data collection for this study included system related issues. The PI met with
CCTS consultant to categorize data collection identifiers designed to pull data from UK’s patient
database. The data collection period was from September 2019 to January 2020. Next, the data was
reevaluated by the PI who verified each variable and cohort assignments for each participant twice in
the electronic health record before statistical analysis in February 2020. Initially, the study had 577 total
participants after CCTS’ final data collection. The primary researcher found the following exclusion
criteria was mistakenly included in the initial data received from CCTS: opioid use disorder, continuous
opioid PCAs, and those not receiving both scheduled acetaminophen and methocarbamol; these
patients were excluded. Duplicate MRNs were also discovered especially in patients having both a CABG
and valve surgery in one procedure, so those patients were also excluded. After these exclusions, a total
of 77 patients were included. A table of study measures utilized in the data collection process for CCTS is
included in appendix three.

Data Analysis
The finalized data was analyzed by the PI and university statistician, Amanda Wiggins. Material
resources involved in the study included the PI’s already purchased computer, flash drive, IBM SPSS
software version 24, and printer with paper and ink.
Descriptive statistics were utilized in IBM SPSS version 24 to examine percentages of the
nominal variables of gender, procedure type, discharged on opioids, hospital LOS, and race while the
continuous variables of age, sum of opiates, sum of nausea medications, and individual counts of
oxycodone/ hydrocodone/ hydromorphone/ morphine/ promethazine/ ondansetron were analyzed
descriptively via measures of central tendency and dispersion (mean, median, minimum, maximum,
standard deviation) for both cohorts. A demographic variable table and objective variable table is
included in appendices four and five, respectfully.
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Comparisons between cohorts (scheduled versus non-scheduled) were conducted using the
chisquare test of association for nominal variables, or two-sample t-test for continuous measures. An
alpha level of .05 was used to determine statistical significance.

RESULTS
A total of 77 patients were included in the retrospective study divided into two cohorts. The
scheduled cohort had a total of 27 patients, and non-scheduled cohort had a total of 50. The mean age
for scheduled cohort was 60.8 while non-scheduled was 59.5. Both cohorts had more male participants
than females; the scheduled cohort (51.9 percent males) and non-scheduled cohort (64 percent males).
Overall, 97.4 percent (n=75) of all 77 participants identified their race as white. The scheduled cohort
consisted of 14 CABGs (51.9 percent), 9 valves (33.3 percent), and 4 CABG and valve (14.8%). The
nonscheduled cohort was comprised of 35 CABGs (70 percent), 13 valves (26 percent), and 2 CABG and
valve (4 percent). Overall, 51.9 percent (n= 40) of all patients were hospitalized more than one week
while 48.1 percent (n=37) were less than one week. The variables hospital LOS greater than one week
and less than one week was analyzed with a chi square test of independence and produced a p value of
.057 indicating a slight significant difference between the two groups. This indicates an association exists
between scheduling acetaminophen and methocarbamol and hospital length of stay. A demographic
variable table is included in appendix four.
The first objective analyzed resulted in the scheduled cohort having a sum of opioids mean of
23.5, with a standard deviation of 12.5; the non-scheduled cohort had a sum of opioids mean of 25.5
with a standard deviation of 10.6. Sum of opioids was defined as total number of occurrences of opioid
administrations per patient on each patient’s MAR (ex. morphine count + oxycodone count +
hydrocodone count = sum of opioids). There was no significant difference in means between the two
cohorts indicating no significant difference between the two cohorts of scheduling (acetaminophen and
methocarbamol) and postoperative opioid use (p= .47).
In the second objective, there was no significant difference between the two cohorts (scheduled
and non- scheduled) of hospital length of stay less than one week and greater than one week and sum of
opioids (p=.07, .533 respectively); however, less than one week, the p value was substantially lower
(p=.07) and the mean scores of scheduled less than one week and sum of opioids, n=9 with a mean of
15.6 (SD 6.1), non-scheduled less than one week n=28 with a mean of 22.1 (SD 9.8). This indicated an
independent difference between those receiving the scheduled medications (acetaminophen/
methocarbamol) and hospital length of stay.
The third objective statistically studied yielded no significant association (p= .753) between
discharged on opioids and scheduled versus non- scheduled cohorts. In the scheduled cohort (n=27),
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44.4 percent (n=12) were not discharged home on opioids while 48.1 percent were (n=13); however, 7.4
percent were unknown (n=2). In the non-scheduled cohort (n=50), 36 percent (n=18) were not
discharged home on opioids, 54 percent were (n=27), and 10 percent were unknown (n=5). 17.4 percent
collectively were unknown.
The fourth objective analyzed produced no significant difference between the two cohorts of
scheduled and non-scheduled (p= .107) and sum of nausea medications. The means of the scheduled
and non-scheduled cohorts were 3.222 (SD 2.736), and 2.08 (SD 3.04) respectfully, which indicated no
association between scheduled and non-scheduled cohorts and postoperative antiemetic use. Sum of
nausea medications was defined as total number of occurrences of ondansetron and promethazine
administrations on each patient’s MAR (ex. ondansetron count + promethazine count = sum of nausea
medications).
An objectives variable table is included in appendix five.

DISCUSSION
In this retrospective study the effects of scheduling acetaminophen and methocarbamol
postoperatively to assess outcomes of postoperative opioid use and the associated side effects of
dependence and nausea were statistically analyzed along with single dose cost analysis of the study’s
scheduled/ non- scheduled medications. Overall, the study did not produce statistical independence in
any of the objectives analyzed but when compared to the limited existing research some similarities and
differences exist. The aims and clinical significance of the study results will be discussed below.
Aim One: Does scheduling acetaminophen and methocarbamol postoperatively impact the
average postoperative opioid use among cohorts?
Unfortunately, this study did not see a significant difference in the sum of opioids consumed
postoperatively between the scheduled and non- scheduled cohorts (p=.470); however, this result does
not coincide with the postoperative pain management guidelines that claim postoperatively scheduling
acetaminophen alone can reduce opioid use (American Pain Society, 2016; Engelman et al., 2019). One
could argue that this study may produce different results should the definition of “scheduling” be
altered to include more patients in the scheduled cohort. During the data collection process, many
participants were assigned to the non-scheduled cohort because they missed the 24-hour window of
receiving methocarbamol and acetaminophen four times in a 24-hour period by minutes to hours. Not
only might this balance the cohort sample sizes (n= 27 and 50), but also might produce altered mean
results for opioid use between the two cohorts along with altering all the other measured outcome
results. Adjustments in the exclusion criteria might also increase the overall sample size which is further
discussed in the limitations section.
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Aim Two: Does scheduling acetaminophen and methocarbamol postoperatively impact the
average postoperative opioid use among cohorts when examining patients with hospital length of
stay less than one week and greater than one week?
When comparing p values of all demographic data collected in this study, a determination was
made that the variable of hospital LOS (greater than and equal to or less than one week) had the most
significance (p=.057), see appendix four. This led to a statistical comparison of the sum of opioids with
respect to hospital LOS greater than and equal to or less than one week for both cohorts (p=.533 and .07
respectfully). Though this outcome did not produce a statistical difference, one should note the
individuals in the scheduled cohort staying less than one week had a mean opioid use of 15.6 while
individuals in the non- scheduled cohort staying less than one week had a mean opioid use of 22.1. This
could be of use on an individual consumption basis (15 opioid doses during hospital stay is better than
22) or on an individual cost basis (15 opioids cost less than 22), but also supports the need for more
research involving postoperative opioid use associated with hospital length of stay especially among the
cardiac surgery patient to determine statistical difference in a larger, more equal cohort sample size.
Aim Three: Does scheduling acetaminophen and methocarbamol postoperatively impact the average
amount of those discharged home on opioids among cohorts?
The synthesis of evidence supports that even opioid naïve surgical patients are at risk for
dependence (Brescia et al., 2019; Sun, Darnell, Baker, & Mackey, 2016; Brummett et al., 2017; Clarke et
al., 2014; Calcaterra et al., 2015; Mechcatie, 2018) and this study theoretically included all opioid naïve
patients as patients were excluded with chronic pain disorders like fibromyalgia/ chronic back pain
(likely prescribed opioids) and patients with diagnosed opioid use disorder. Granted, unknown
preoperative opioid abuse and prescribed opioid use could be confounding the sample results which
might also be warranted to consider when developing future research.
This study did not produce a statistical difference when comparing scheduled and nonscheduled cohorts to those discharged home on opioids. One Canadian retrospective cohort study found
among opioid naïve patients who had major elective surgery including cardiac procedures- 49 percent
were discharged home with an opioid prescription (Clarke, Soneji, Ko, Yun, & Wijeysundera, 2014).
When comparing this research to this study’s results, the scheduled cohort had a slightly lower
percentage of being discharged on opioids (48.1 percent), but when considering the non- scheduled
cohort’s higher percentage of being discharged on opioids (54 percent) the scheduling may be
warranted to reduce this hospital region’s average percentage of cardiac surgery patients receiving
opioids at discharge. Future research is warranted. The alteration of including a 24 hour (+ or – 4 hours)
for the scheduled cohort, as previously stated, could also produce more significant results among the
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discharged on opioid percentages between the two cohorts. One should also note 17.4 percent in the
entire study were not known if they were discharged home on opioids.

Aim Four: Does scheduling acetaminophen and methocarbamol postoperatively impact the
average postoperative antiemetic use among cohorts?
The literature states nausea is a side effect reported to occur in 25 percent of patients receiving
opioids. No statistical difference was noted when comparing the sum of nausea medication means to
the cohorts (p=.107) which supports the first objective’s finding of no significant difference between
cohorts’ sum of opioid means (23.5= scheduled cohort, 25.5= non-scheduled cohort). Indicating both
cohorts consumed opioids similarly; therefore, had similar requirements for antiemetics
postoperatively.

IMPLICATIONS for PRACTICE and FUTURE RESEARCH
Literature supports clinical guidelines from the American Pain Society (2016), Enhanced
Recovery After Surgery Society and European Society of Thoracic Surgeons (2019) for scheduling
acetaminophen postoperatively to reduce opioid consumption and should be a considered practice
change for UK’s cardiac surgery patients. Future research is warranted involving the scheduling of
acetaminophen and methocarbamol postoperatively in cardiac surgery patients as no studies exist
currently.
When developing these future studies, one could argue hospital LOS should be a considered
factor due to this study’s findings. LOS could be altered related to procedure as CABGs usually have a
hospital LOS seven days while valves are 14 days at UK Chandler Hospital. LOS could also be altered
related to common complications that should be considered. Future research is needed for cardiac
surgery patients and those discharged home on opioids. It would be interesting to see this study’s
results with an altered “scheduling” definition to include patients receiving acetaminophen and
methocarbamol greater than or equal to four times in a 24-hour period (+ or – four hours).
Another aspect for future research could include a more in-depth consultation with CCTS and
the data collectors to address ways to mitigate the technological errors encountered with all the
medication counts on the MARs and other technologically related issues in data collecting. Resolving
these issues would give the primary investigator more time to address ways to increase reliability and
validity within the study, and to disseminate future results among the disciplines.
In the future, an extensive cost analysis could be valuable in this study to determine which
combinations of medications (acetaminophen/ methocarbamol or opioids) cost the hospital less.
Obviously, the study could be strengthened if the acetaminophen/ methocarbamol combination was
cheaper than opioids; however, if opioids were cheaper one could see why providers would want to
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abstain from ordering acetaminophen/ methocarbamol due to the additional cost it would present the
hospital.
Dissemination of the surgical guidelines published by the American Pain Society (2016) and The
Enhanced Recovery After Surgery Society (2019) that promote scheduling acetaminophen
postoperatively could occur in an educational in-person session to the providers and cardiac surgery
service line of this study and serve as beneficial along with this study’s clinically relevant findings that
were previously discussed. A pre and post educational analysis among providers and nurses could be
included to verify the educational efficacy. This postoperative educational dissemination session could
also include a compilation of various complementary pain treatment regimens where various methods
of aromatherapy, acupuncture, massage, music, etc. are presented. If Kolcaba’s Comfort Theory
Construct of Transcendence is ever attainable, alternative therapies should be discussed in order to
overcome and rise above opioid dependence and associated side effects.
A more involved communicative approach between all disciplines in this study would also serve
to be beneficial when tackling the technological obstacles encountered within the data collection
process. This consistent communication could’ve decreased the time to validate data and could’ve also
prevented technological errors.

LIMITATIONS
This study was subject to several limitations. The first limitation was overall time. If more time
were feasible for the data collection process, then the primary investigator could have included a less
strict “scheduling” definition to involve more patients in the study which would eliminate the limitation
of small sample size. Instead of the scheduling definition adhering to a strict time frame of receiving the
scheduled medications greater than or equal to four times in a 24-hour period, a plus or minus fourhour
window could’ve been used which would’ve included many more patients.
This small sample size limitation could have also been increased if other exclusion criteria was
omitted. Many patients were excluded if they had opioid use disorder, fibromyalgia, or chronic back
pain. Minimal diversity among the patient population was another limitation due to the hospital residing
in a region where the majority of the population was Caucasian. Selection was not random, as strict
inclusion and exclusion criteria was used among the cardiac surgery patient population.
Another limitation was this was a single-center study where multiple doses and routes of the
medications were used. To increase the reliability of the study, one might suggest a multi-center
approach where cardiac surgery patients are given the same doses of scheduled, non-scheduled, and
opioid medications. The last limitation could include that one of the opioid medications examined in
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both cohorts (hydrocodone) also contained acetaminophen 325 mg and was not counted towards the
scheduled acetaminophen/ cohort which could threaten internal validity by confounding the results.
One ethical limitation is that the project author was employed as a registered nurse in the unit
where the study took place. This means the study’s author could have provided care for the study
participants which could produce threats to internal validity; however, at the time the care was
provided, the author would not have known about the patients’ participation because of the
retrospective nature of the study. The participants were not included until the care had already been
provided and their discharge completed.

CONCLUSION
In conclusion, limited research exists studying postoperative opioid consumption and opioid
associated effects among cardiac surgical patients when scheduling acetaminophen and
methocarbamol. This study produced no statistically significant differences among the objectives
analyzed; however, various clinically significant objectives were discussed. Some of these clinically
significant objectives involved the consideration of hospital LOS when scheduling acetaminophen and
methocarbamol postoperatively with respect to reducing postoperative opioid use and scheduling
acetaminophen and methocarbamol with respect to those being discharged home on opioids. Future
research is needed regarding contributing factors towards hospital LOS and alternative modalities
contributing towards hospital LOS. The study supports the need for altering the “scheduled” inclusion
definition to include a grace period of receiving methocarbamol and acetaminophen greater than or
equal to four times in 24 hours plus or minus four hours along with less strict exclusion preoperative
diagnoses criteria. These adjustments in research would increase sample size and potentially produce a
more reliable study. Literature supports clinical guidelines from the American Pain Society (2016) and
Enhanced Recovery After Surgery Society (2019) for scheduling acetaminophen postoperatively to
reduce opioid use and should be a considered practice change for UK’s cardiac surgery patients based on
findings produced by this study’s review of literature and clinically significant results. In future research,
hospital LOS and ways to mitigate those discharged home on opioids should be considered as well as a
more in-depth multidisciplinary communicative approach among the disciplines involved. Limitations to
this study included time constraints, strict inclusion and exclusion criteria, small sample size with
minimal diversity, and a single-center study where multiple doses and routes of all the medications
studied were utilized. This study contributes to the knowledge of the effects related to scheduling
postoperative acetaminophen and methocarbamol among cardiac surgery patients and has the
potential to offer insight on future study designs. Should Kolcaba’s Comfort Theory Construct of
Transcendence ever be attainable, consideration must be made towards alternative postoperative
therapies such as scheduling acetaminophen and methocarbamol.
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APPENDICES
Appendix One- Kolcaba’s Comfort Theory Conceptual Framework Experienced by Cardiac Surgical
Patients Through Scheduling Acetaminophen and Methocarbamol

Relief of
initial pain
post-op with
new therapy

Types of Comfort
Experienced by
Cardiac Surgical
Patients through

Ease (calm) of new post-op
pain management therapy
working to reduce opioid

scheduling

related effects of

acetaminophen/

dependence and nausea

methocarbamol in

while providing adequate

addition to standard

pain control.

opioid therapy

Transcendence of patient to
overcome and rise above
opioid related problems
(dependence, nausea,) when

they leave the hospital
(discharge).
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Appendix Two- Synthesis of Evidence Table

Objectives

Postoperative
opioid use

Postoperative
opioid
dependence

Office of Drug
Control Policy,
2018
Sun et al., 2016

X

X

X

Brummet et al.,
2017

X

X

Clarke et al., 2014

X

X

Calceterra et al.,
2015

X

X

Mechcatie, 2018

X

X

Clark &
Schumacher, 2017

X

X

Hirjii et al., 2019

X

Shah et al., 2017

X

Postoperative
opioid related
nausea

Kane-Gill et al.,
2014

X

Swegle &
Logemann, 2006

X

American Pain
Society, 2016

X
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Postoperative
Scheduling
Acetaminophen

X

Postoperative
Scheduling
Methocarbamol

Urman et al., 2014

X

Engleman et al.,
2019

X

X

Looke & Kluth,
2013

X

X

MicNicol et al.,
2011

X

X

Jelacic et al., 2016

X

X

Toms et al., 2008

X

X

Mamoun et al.,
2016

X

X

Hidalgo & Pusic,
2005

X

Enhanced
Recovery After
Surgery Society
and European
Society of Thoracic
Surgeons, 2019

X

X

X

X
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Appendix ThreeTABLE of STUDY MEASURES
Measures

Description

Level of

Data Source

Measurement
OUTCOMES
Number of

The number of total occurrences

Continuous

CCTS provided the data and

occurrences of

of received opioids was based on

the primary researcher’s

opioid

the sum of total opioid

analyzation of the patients’

administration

medications being scanned into

electronic medical record

(morphine,

the patients’ medication

MAR opioid administration

hydromorphone,

administration records (MARs)

included the following

oxycodone,

which is a required nursing

opioids: morphine,

hydrocodone)

practice at UK.

hydrocodone, oxycodone,

throughout

hydromorphone. Measures of

hospital stay for
cohort one and
two.

central tendency were used to
compare the mean number of
the sum of opioid occurrences
between the two groups via
SPSS.

Number of

The number of total occurrences

occurrences of

of received opioids was based on

the primary researcher’s

opioid

the sum of total opioid

analyzation of the patients’

administration (as

medications being scanned into
the patients’ MARs for both
groups which is a required
practice at UK.

MARs opioid administrations

above) for cohort
one and two

Continuous

CCTS provided the data and

included the following
opioids: morphine,

based on length

hydrocodone, oxycodone,

of stay (LOS) less
than one week
and more than
one week

hydromorphone with respect
to their hospital LOS.
Measures of central tendency
were used to compare the
mean number of total opioid

27

occurrences between the two
cohorts based on a length of
stay less than one week and
more than one week via SPSS.

Nausea via

The number of total occurrences

documented

of antiemetic administration

the primary researcher’s

number of

being scanned into the patients

analyzation of patients’

occurrences of

MARs . Scanning medication is a
required nursing practice at UK.

electronic medical record

antiemetic

Continuous

CCTS provided the data and

MAR antiemetic

administration

administration including

(ondansetron,

ondansetron and

promethazine)

promethazine. Measures of

throughout

central tendency were used to

hospital stay for
cohort one and
two.

compare the mean number of
antiemetic administrations
between the two cohorts via
SPSS.

Cost Analysis

Consultation with UK Healthcare

Continuous

UK Pharmacy

Nominal

CCTS collected data from the
patients’ electronic medical
record for those discharged

Pharmacy Office with the goals
of obtaining the individual
hospital purchasing cost of the
following opioids: morphine,
hydromorphone, oxycodone,
and hydrocodone. Another goal
was to obtain an individual
hospital purchasing cost of
acetaminophen and
methocarbamol.
Percentage of
opioid

Discharge medications were
analyzed for the following
opioids: oxycodone and

prescriptions at
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discharge
between two
cohorts

hydrocodone. Example: yes they
were discharged on opioids, no
they were not, or unknown.

home on opioids and those
that were not. Percentages
were calculated among the
two cohorts via SPSS.

DEMOGRAPHIC
VARIABLES
Gender

Male vs Female

Nominal

CCTS provided the data and
the primary researcher
examined male vs female
status in patients’ electronic
medical record for both
cohorts. Percentages were
calculated among the two
cohorts with analysis in SPSS.

Age

Mean age in years

Continuous

CCTS provided the data and
the primary researcher
examined age in years among
study participants’ electronic
medical record in both cohorts
with analysis in SPSS.

Procedure Type

CABG, VALVE, CABG and VALVE

Nominal

CCTS provided the data and
the primary researcher
examined procedure type
among study participants’
electronic medical record in
both cohorts. Percentages
were calculated among the
two cohorts with analysis in
SPSS.

Hospital Length of
Stay (LOS)

Less than one week vs more than
one week
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Nominal

CCTS provided the data and
the primary researcher

examined hospital LOS among
study participants’ electronic
medical record for both
cohorts and percentages were
calculated with analysis in
SPSS.
Race

White vs Non-White

Nominal

CCTS provided the data and
the primary researcher
examined race among study
participants’ electronic health
record for both cohorts and
percentages were calculated
with analysis in SPSS.
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Appendix Four- Demographic Variable Table
Scheduled
(n =27)
Mean (SD) or n (%)

Not scheduled
(n = 50)
Mean (SD) or n (%)

p

Age

60.81 (9.6)

59.54 (12.1)

.639

Gender
Male
Female

14 (51.9%)
13 (48.1%)

32 (64.0%)
18 (36.0%)

.300

Procedure type
CABG
Valve
CABG and Valve

14 (51.9%)
9 (33.3%)
4 (14.8%)

35 (70.0%)
13 (26.0%)
2 (4.0%)

Hospital LOS
Less than one week
One week or more

9 (33.3%)
18 (66.7%)

28 (56.0%)
22 (44.0%)

.057

Race
White
Non-white

27 (100%)
0 (0%)

48 (96%)
2 (4%)

.292

.144

Appendix Five- Objectives Variable Table
Objectives

Objective 1

Sum of Opioids

Objective 2

Sum of Opioids with
hospital length of stay
Less than one week
Greater than one
week

Objective 3

Objective 4

Discharged on Opioids
Yes
No
Unknown
Sum of Nausea
Medication

Scheduled
(n =27)
Mean (SD) or n (%)

Not scheduled
(n = 50)
Mean (SD) or n (%)

P

23.5 (12.5)

25.5 (10.6)

.470

n=9, 15.6 (6.1)
n=18, 27.5 (13.1)

n= 28, 22.1 (9.8) n=
22, 29.8 (10.2)

.070
.533

13 (48.1%)
12 (44.4%)
2 (7.4%)

27 (54%)
18 (36%)
5 (10%)

.753

3.22 (2.7)

2.08 (3.0)

.107
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